Asking artificial intelligence for advice can be tempting. Powered by large language models (LLMs), AI chatbots are available 24/7, are often free to use, and draw on troves of data to answer questions.
Nick Yaitsky is a seasoned technology leader with deep expertise in digital platforms and application engineering. As Vice President and Head of Digital Platforms at Wellstar Health System (since 2020), he drives digital innovation for patient and provider engagement, leading product development, engineering, automation, and data systems.
Previously, Nick served as Senior Vice President of Application Engineering at Sharecare, Inc., where he spearheaded data integration and content delivery systems. His earlier career includes roles as Senior Software Architect at KIT digital, Lead Developer at Multicast Media, and developer positions at MammalFish and Skillfusion Software.
Nick holds both a Bachelor of Science and a Master of Science in Computer Science from the Georgia Institute of Technology.
Healthcare payment systems in the U.S. are complex, involving multiple stakeholders, dense billing structures, and administrative hurdles. For patients, this often leads to surprise bills, care delays, and a lack of cost transparency. Providers spend considerable time navigating reimbursement, while payers invest heavily in ensuring payment accuracy—diverting focus and resources from care delivery and creating strategic friction between payers and providers. These drive up costs, erode trust, and hinder outcomes. While initiatives like price transparency and value-based models aim to simplify the system, adoption remains inconsistent. This discussion will explore the impact of regulatory shifts, technology, and evolving payment models on patient care and experience.
Event Details:
Date: Tuesday, May 14th
Time: 5:00 PM – 7:00 PM
Format: 60 minute panel discussion
Location: Atlanta Technology Park
Audience: 60–80 participants including health tech executives, leaders from provider organizations and payer entities, and select inv
The Marcus Autism Center Spring Symposium (formerly the Autism Treatment Symposium) is a one-day symposium during which faculty, staff, and other community professionals will disseminate their latest treatment research.
Invited Speaker:
Vivian Ibanez, PhD, BCBA-D
University of Florida Health Center for Autism and Neurodevelopment, Pediatric Feeding Disorders
Topic: "The Importance of Secondary Analyses During Behavioral Feeding Treatment"
Click "RSVP" below to register.
Free BACB CEs available!
For questions, please contact Dr. Chelsea Fleck at Chelsea.Fleck@choa.org.
CF-AIR will be hosting Charles Esther, MD, PhD, Professor, Pediatric Pulmonology at University of North Carolina, Chapel Hill, for a virtual visit and talk on "Mucus, Microbes, and Inflammation: the Vicious Vortex in CF Airways Disease." Participants can join in-person in Emory Children's Center room 302, or virtually via Zoom.
George Ferry Young Investigator Development Award
This grant is awarded to support a meritorious clinical, quality improvement, translational or basic science research project related to diseases of the gastrointestinal tract, liver, pancreas, or nutritional disorders of children.
Eligibility:
Applicants must:
New institutional awards of up to $10,000,000 to stimulate the development of strong research, education, and public communications connections between fields that aim to understand and mitigate the impact of climate change on human health. In general, this award will support institutions or consortia that are already moving toward establishing themselves as centers of excellence for understanding climate change’s impact on human health and for leadership in climate education OR public communication around climate and health.
Dr. Scherer is an Assistant Professor in the Division of Infectious Diseases in the Department of Medicine at Emory University School of Medicine. She is also Director of the Hope Clinic Vaccine and Treatment Evaluation Unit (VTEU) Research Laboratory and a full member of both the Microbiology and Molecular Genetics and Immunology and Molecular Pathogenesis graduate programs in the Laney Graduate School. Dr. Scherer joined Emory on March 1, 2020.
Dr. Scherer received a bachelor of science degree summa cum laude in Chemistry from the University of Arkansas. Dr. Scherer pursued graduate studies at The Scripps Research Institute in La Jolla, California, where she was selected into a joint PhD/DPhil program with the University of Oxford in the UK. After focusing largely on mechanisms of HIV inhibition by broadly neutralizing anti-HIV antibodies for her graduate work, Dr. Scherer transitioned to cellular immunology research in HIV and HPV vaccinology for her postdoctoral studies in the Department of Immunology at the University of Washington and in the Human Biology Division at the Fred Hutchinson Cancer Center in Seattle. Following her postdocs, Dr. Scherer transitioned to lead an antibody discovery team in biotech for approximately two years at Seagen, the then largest oncology therapeutics biotech in the Seattle area. Realizing her passion for infectious disease vaccine research, Dr. Scherer returned to the field as a fellow in the Respiratory Disease Branch at the Centers for Disease Control and Prevention for two years before joining Emory as faculty.